Liminatus Pharma explores digital asset vehicle for up to $500 million
Liminatus Pharma is exploring the creation of a digital asset investment vehicle worth up to $500 million, signaling a major biotech player’s entry into blockchain-based financing. Liminatus Pharma, a clinical-stage biopharmaceutical company, is considering launching a digital asset investment vehicle with a potential size of $500 million. The initiative highlights the growing convergence between traditional life sciences and blockchain technology, as companies seek alternative financing methods and innovative asset strategies in the digital economy.
admin
0
0
